SF
HQL

Synovus Financial’s abrdn Life Sciences Investors HQL Stock Holding History

Synovus Financial’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,060
Closed -$26.3K – 1021
2015
Q3 		$24K Buy
1,060
+346
+48% +$9.69K ﹤0.01% 709
2015
Q2 		$20K Hold
714
– – ﹤0.01% 736
2015
Q1 		$20K Buy
+714
New +$19.5K ﹤0.01% 764

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Synovus Financial's HQL Position: Q4 2015 in Review

Synovus Financial sold out of abrdn Life Sciences Investors (HQL) in Q4 2015, closing a stake of 1,060 shares — an estimated $26.3K sold.

Synovus Financial first reported a position in HQL in Q1 2015 and held it in 3 quarters. The position peaked at $24K in Q3 2015. 52 funds tracked by Wall St. Rank hold HQL as of Q4 2015.

  • Synovus Financial reported no remaining abrdn Life Sciences Investors position as of Q4 2015 after selling out during the quarter.
  • Synovus Financial sold 1,060 abrdn Life Sciences Investors shares in Q4 2015, an estimated $26.3K.
  • Synovus Financial first reported a position in abrdn Life Sciences Investors in Q1 2015 and held it in 3 quarters.
  • Synovus Financial's abrdn Life Sciences Investors position peaked at $24K in Q3 2015.
  • 52 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2015.

Based on Synovus Financial's 13F filing for Q4 2015, filed 8 Feb 2016.